The combination of dAurA383 and dAurA450 sequentially degrades the mitotic and interphase AURKA, impairs AML proliferation, relieves the hook effect, and abrogates acute myeloid leukemia stem cells. This evidence concerns the gene AURKA and acute myeloid leukemia.